The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations - PubMed (original) (raw)
Guideline
. 2015 Jun 2;162(11):777-84.
doi: 10.7326/M14-2385.
Georgia Salanti, Deborah M Caldwell, Anna Chaimani, Christopher H Schmid, Chris Cameron, John P A Ioannidis, Sharon Straus, Kristian Thorlund, Jeroen P Jansen, Cynthia Mulrow, Ferrán Catalá-López, Peter C Gøtzsche, Kay Dickersin, Isabelle Boutron, Douglas G Altman, David Moher
- PMID: 26030634
- DOI: 10.7326/M14-2385
Free article
Guideline
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
Brian Hutton et al. Ann Intern Med. 2015.
Free article
Abstract
The PRISMA statement is a reporting guideline designed to improve the completeness of reporting of systematic reviews and meta-analyses. Authors have used this guideline worldwide to prepare their reviews for publication. In the past, these reports typically compared 2 treatment alternatives. With the evolution of systematic reviews that compare multiple treatments, some of them only indirectly, authors face novel challenges for conducting and reporting their reviews. This extension of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement was developed specifically to improve the reporting of systematic reviews incorporating network meta-analyses. A group of experts participated in a systematic review, Delphi survey, and face-to-face discussion and consensus meeting to establish new checklist items for this extension statement. Current PRISMA items were also clarified. A modified, 32-item PRISMA extension checklist was developed to address what the group considered to be immediately relevant to the reporting of network meta-analyses. This document presents the extension and provides examples of good reporting, as well as elaborations regarding the rationale for new checklist items and the modification of previously existing items from the PRISMA statement. It also highlights educational information related to key considerations in the practice of network meta-analysis. The target audience includes authors and readers of network meta-analyses, as well as journal editors and peer reviewers.
Comment in
- The PRISMA Extension Statement.
Tian JH, Ge L, Li L. Tian JH, et al. Ann Intern Med. 2015 Oct 6;163(7):566. doi: 10.7326/L15-5144. Ann Intern Med. 2015. PMID: 26436628 No abstract available. - The PRISMA Extension Statement.
Hutton B, Moher D, Cameron C. Hutton B, et al. Ann Intern Med. 2015 Oct 6;163(7):566-7. doi: 10.7326/L15-5144-2. Ann Intern Med. 2015. PMID: 26436629 No abstract available.
Similar articles
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. Liberati A, et al. J Clin Epidemiol. 2009 Oct;62(10):e1-34. doi: 10.1016/j.jclinepi.2009.06.006. Epub 2009 Jul 23. J Clin Epidemiol. 2009. PMID: 19631507 - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. Liberati A, et al. Ann Intern Med. 2009 Aug 18;151(4):W65-94. doi: 10.7326/0003-4819-151-4-200908180-00136. Epub 2009 Jul 20. Ann Intern Med. 2009. PMID: 19622512 - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. Liberati A, et al. BMJ. 2009 Jul 21;339:b2700. doi: 10.1136/bmj.b2700. BMJ. 2009. PMID: 19622552 Free PMC article. - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. Liberati A, et al. PLoS Med. 2009 Jul 21;6(7):e1000100. doi: 10.1371/journal.pmed.1000100. Epub 2009 Jul 21. PLoS Med. 2009. PMID: 19621070 Free PMC article. - Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
Welch V, Petticrew M, Petkovic J, Moher D, Waters E, White H, Tugwell P; PRISMA-Equity Bellagio group. Welch V, et al. J Clin Epidemiol. 2016 Feb;70:68-89. doi: 10.1016/j.jclinepi.2015.09.001. Epub 2015 Sep 5. J Clin Epidemiol. 2016. PMID: 26348799
Cited by
- Comparison of Anesthetics for Laryngeal Mask Airway Insertion: A Network Meta-Analysis.
Goertzen C, Goertzen E, Zanjir M, Dare C, Azarpazhooh A, Wong M. Goertzen C, et al. Anesth Prog. 2024 Jul 8;71(2):58-75. doi: 10.2344/22-00033. Anesth Prog. 2024. PMID: 39503130 - Comparison of the efficacy and safety of mini-percutaneous nephrolithotomy versus retrograde intrarenal surgery for the treatment of kidney stones in overweight or obese patients: a systematic review and meta-analysis.
Qiu M, Shi H, Yang F, Li P, Fu S, Wang J, Wang H, Yang Q, Zuo Y, Hai B, Zhang J. Qiu M, et al. BMC Urol. 2024 Nov 6;24(1):243. doi: 10.1186/s12894-024-01588-4. BMC Urol. 2024. PMID: 39501220 Free PMC article. - Effects of Qingjin Huatan decoction on pulmonary function and inflammatory mediators in acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Du X, Chen Y, Zhang R, Shi L, Ren Y. Du X, et al. Front Pharmacol. 2024 Oct 18;15:1466677. doi: 10.3389/fphar.2024.1466677. eCollection 2024. Front Pharmacol. 2024. PMID: 39494348 Free PMC article. - Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials.
Duo H, Yang Y, Zhang G, Chen Y, Cao Y, Luo L, Pan H, Ye Q. Duo H, et al. Front Pharmacol. 2024 Oct 17;15:1430724. doi: 10.3389/fphar.2024.1430724. eCollection 2024. Front Pharmacol. 2024. PMID: 39484168 Free PMC article.
Publication types
MeSH terms
Grants and funding
- G0902118/MRC_/Medical Research Council/United Kingdom
- 16895/CRUK_/Cancer Research UK/United Kingdom
- 116573/CAPMC/ CIHR/Canada
- CGV 121171/CAPMC/ CIHR/Canada
- MR/K023233/1/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Miscellaneous